The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}

Peer Review reports

Original Submission
3 Nov 2022	Submitted	Original manuscript
3 Jan 2023	Reviewed	Reviewer Report - Alexander Gough
4 Apr 2023	Reviewed	Reviewer Report - Zhiqing He
7 Apr 2023	Reviewed	Reviewer Report - Chunyu Zeng
16 Apr 2023	Reviewed	Reviewer Report - Yu Deng
3 Jun 2023	Author responded	Author comments - Mengzhuo Xu
Resubmission - Version 2
3 Jun 2023	Submitted	Manuscript version 2
21 Jun 2023	Reviewed	Reviewer Report - Alexander Gough
29 Jun 2023	Reviewed	Reviewer Report - Chunyu Zeng
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
12 Oct 2023	Editorially accepted
28 Nov 2023	Article published	10.1186/s13063-023-07726-x

Back to article page